Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published June 6, 2024 | in press
Journal Article

Towards realizing nano-enabled precision delivery in plants

Abstract

Nanocarriers (NCs) that can precisely deliver active agents, nutrients and genetic materials into plants will make crop agriculture more resilient to climate change and sustainable. As a research field, nano-agriculture is still developing, with significant scientific and societal barriers to overcome. In this Review, we argue that lessons can be learned from mammalian nanomedicine. In particular, it may be possible to enhance efficiency and efficacy by improving our understanding of how NC properties affect their interactions with plant surfaces and biomolecules, and their ability to carry and deliver cargo to specific locations. New tools are required to rapidly assess NC–plant interactions and to explore and verify the range of viable targeting approaches in plants. Elucidating these interactions can lead to the creation of computer-generated in silico models (digital twins) to predict the impact of different NC and plant properties, biological responses, and environmental conditions on the efficiency and efficacy of nanotechnology approaches. Finally, we highlight the need for nano-agriculture researchers and social scientists to converge in order to develop sustainable, safe and socially acceptable NCs.

Copyright and License

© Springer Nature Limited 2024.

Acknowledgement

This material is based on work supported by the National Science Foundation and USDA under grants CBET 2222373 and USDA 2022-67021-38078 to G.V.L., J.P.G., N.F.S., K.D.R. and C.O.H., and National Science Foundation grants CBET 2133568 to G.V.L. and J.P.G., and CBET 2134535 to J.P.G., G.V.L. and N.F.S. A.A. received funding from the European Research Council under grant 101041729.

Contributions

G.V.L., J.P.G., N.F.S., K.D.R. and C.O.H. conceived the idea for the workshop and resulting paper. All authors contributed to the ideas in the paper and helped to write, review and revise the manuscript text before submission.

Conflict of Interest

N.F.S. is a co-founder of, has equity in, and has a financial interest with Mosaic ImmunoEngineering Inc. N.S.F. is also a co-founder of, and serves as manager of Pokometz Scientific LLC, under which she is a paid consultant to Flagship Labs 95 Inc. and Arana Biosciences Inc. G.V.L. and J.P.G. received research funding from BASF for topics related to this review. The other authors declare no competing interests.

Additional details

Created:
June 11, 2024
Modified:
June 11, 2024